80 FR 59169 - The National Institutes of Health FY 2016-2020 Strategic Plan To Advance Research on the Health and Well-Being of Sexual and Gender Minorities (SGM) Request for Comments

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 190 (October 1, 2015)

Page Range		59169-59170
FR Document		2015-25026

The National Institutes of Health (NIH) is developing a strategic plan to guide the agency's efforts and priorities in SGM research over the next five years (2016-2020). The purpose of this notice is to seek input from researchers in academia and industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, public agencies, and other interested members of the public about proposed goals and objectives for advancing research and other research-related activities with SGM populations. Specific organizations, such as advocacy or professional groups are encouraged to submit a single response that reflects the views of their organization and membership as a whole.

Federal Register, Volume 80 Issue 190 (Thursday, October 1, 2015)

[Federal Register Volume 80, Number 190 (Thursday, October 1, 2015)]
[Notices]
[Pages 59169-59170]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-25026]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The National Institutes of Health FY 2016-2020 Strategic Plan To 
Advance Research on the Health and Well-Being of Sexual and Gender 
Minorities (SGM) Request for Comments

SUMMARY: The National Institutes of Health (NIH) is developing a 
strategic plan to guide the agency's efforts and priorities in SGM 
research over the next five years (2016-2020). The purpose of this 
notice is to seek input from researchers in academia and industry, 
health care professionals, patient advocates and health advocacy 
organizations, scientific or professional organizations, public 
agencies, and other interested members of the public about proposed 
goals and objectives for advancing research and other research-related 
activities with SGM populations. Specific organizations, such as 
advocacy or professional groups are encouraged to submit a single 
response that reflects the views of their organization and membership 
as a whole.

DATES: To ensure consideration of your comments, responses must be 
received by November 2, 2015.

ADDRESSES: Responses to this notice must be submitted electronically by 
email to [email protected].

FOR FURTHER INFORMATION CONTACT: Dr. Karen Parker, Division of Program 
Coordination, Planning, and Strategic Initiatives, Office of the 
Director, NIH, Building 1, Room 257, 1 Center Drive, Bethesda, MD 
20892, Telephone: 301-451-2055, Email: [email protected].

SUPPLEMENTARY INFORMATION: 

Background

    The NIH developed this Strategic Plan to Advance Research on the 
Health and Wellbeing of Sexual and Gender Minorities (SGM) (http://edi.nih.gov/sgm/research/sgm-strategic-plan.pdf) after substantive 
analysis and integration of portfolio analyses, community input, inter- 
and intra-agency collaborations, and recommendations from the NIH-
commissioned Institute of Medicine report, The Health of Lesbian, Gay, 
Bisexual, and Transgender (LGBT) People: Building a Foundation for 
Better Understanding, released in 2011.
    The NIH SGM Strategic Research Plan promotes and supports the 
advancement of basic, clinical, and behavioral and social sciences 
research to improve the health of people whose sexual orientations, 
gender identities/expressions, and/or reproductive development vary 
from traditional, societal, cultural, or physiological norms. In each 
of these areas, the NIH will coordinate with the NIH intramural and 
extramural program directors and researchers to ensure the advancement 
of SGM-focused research efforts.
    The NIH anticipates that this 5 year plan, which will cover the 
years 2016-2020, will provide the NIH with a framework for progress in 
this area, and that the research that results from this plan will lay a 
foundation for improved health and well-being amongst a group of 
diverse SGM individuals whose health needs have not traditionally 
received strong attention from the research community.

Information Requested

    This notice invites public comment and input on the proposed goals 
and objectives of the strategic plan. We ask that you consider cross-
cutting research opportunities, and/or needs that could have the 
greatest benefit for advancing SGM health.
    To inform implementation of the SGM strategic plan, input is being 
sought on each of the areas identified below.
    (1) Specific priority areas of research in SGM populations.
    (2) Goals and objectives outlined in the plan.
    (3) Any additional comments or information you think would be 
useful to the NIH about the proposed 2016-2020 Strategic Plan to 
Advance Research on the Health and Well-being of Sexual and Gender 
Minorities.
    To ensure consideration of your comments, responses must be 
received by November 2, 2015.

General Information

    All of the following fields in the response are optional and 
voluntary. Any personal identifiers will be removed when responses are 
compiled. Proprietary, classified, confidential, or sensitive 
information should not be included in your response. This notice is for 
planning purposes only and is not a solicitation for applications or an 
obligation on the part of the United States (U.S.) government to 
provide support for any ideas identified in response to it. Please note 
that the U.S. government will not pay for the preparation of any 
comment submitted or for its use of that comment.
    Please indicate if you are one of the following: Grantee, 
administrator, student, patient advocate, Dean/or Institutional 
administrator, NIH employee, or other. If you are an

[[Page 59170]]

investigator, please indicate your career level and main area of 
research interest, including whether the focus is clinical or basic. If 
you are a member of a particular advocacy or professional organization, 
please indicate the name and primary focus of the organization (e.g., 
research support, patient care, etc.) and whether you are responding on 
behalf of your organization (if yes, please indicate your position 
within the organization). Please provide your name and email address.
    Privacy Act Notification Statement: We are requesting your comments 
for the 2016-2020 National Institutes of Health Sexual and Gender 
Minority Strategic Plan. The information you provide may be disclosed 
to the NIH senior staff and those serving on the SGM Research 
Coordinating Committee and to contractors working on our behalf. 
Submission of this information is voluntary. However, the information 
you provide will help to categorize responses by scientific area of 
expertise, organizational entity or professional affiliation.
    Collection of this information is authorized under 42 U.S.C. 203, 
24 1, 2891-1 and 44 U.S.C. 310 I and Section 30 l and 493 of the Public 
Health Service Act regarding the establishment of the National 
Institutes of Health, its general authority to conduct and fund 
research and to provide training assistance, and its general authority 
to maintain records in connection with these and its other functions.

    Dated: September 24, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015-25026 Filed 9-30-15; 8:45 am]
BILLING CODE 4140-01-P

59170 Federal Register / Vol. 80, No. 190 / Thursday, October 1, 2015 / Notices

investigator, please indicate your career applications, the disclosure of which (IITF) currently certified to meet the
level and main area of research interest, would constitute a clearly unwarranted standards of the Mandatory Guidelines
including whether the focus is clinical invasion of personal privacy. for Federal Workplace Drug Testing
or basic. If you are a member of a Name of Committee: National Institute of Programs (Mandatory Guidelines). The
particular advocacy or professional Allergy and Infectious Diseases Special Mandatory Guidelines were first
organization, please indicate the name Emphasis Panel; NIAID Peer Review Meeting. published in the Federal Register on
and primary focus of the organization Date: October 23, 2015. April 11, 1988 (53 FR 11970), and
(e.g., research support, patient care, etc.) Time: 10:00 a.m. to 2:00 p.m. subsequently revised in the Federal
and whether you are responding on Agenda: To review and evaluate contract Register on June 9, 1994 (59 FR 29908);
behalf of your organization (if yes, proposals.
Place: National Institutes of Health, Room
September 30, 1997 (62 FR 51118);
please indicate your position within the 3F21A, 5601 Fishers Lane, Rockville, MD April 13, 2004 (69 FR 19644); November
organization). Please provide your name 20892 (Telephone Conference Call). 25, 2008 (73 FR 71858); December 10,
and email address. Contact Person: Maja Maric, Ph.D., 2008 (73 FR 75122); and on April 30,
Privacy Act Notification Statement: Scientific Review Officer Scientific Review 2010 (75 FR 22809).
We are requesting your comments for Program, Division of Extramural Activities, A notice listing all currently HHS-
the 2016–2020 National Institutes of Room # 3F21A National Institutes of Health, certified laboratories and IITFs is
Health Sexual and Gender Minority NIAID, 5601 Fishers Lane, MSC 9823, published in the Federal Register
Strategic Plan. The information you Bethesda, MD 20852, (240) 669–5025,
maja.maric@nih.gov.
during the first week of each month. If
provide may be disclosed to the NIH any laboratory or IITF certification is
Name of Committee: National Institute of
senior staff and those serving on the suspended or revoked, the laboratory or
Allergy and Infectious Diseases Special
SGM Research Coordinating Committee Emphasis Panel; Global Infectious Disease IITF will be omitted from subsequent
and to contractors working on our Research Administration Development lists until such time as it is restored to
behalf. Submission of this information Award for Low- and Middle-Income Country full certification under the Mandatory
is voluntary. However, the information Institutions (G11). Guidelines.
you provide will help to categorize Date: October 28, 2015. If any laboratory or IITF has
responses by scientific area of expertise, Time: 11:00 a.m. to 12:30 p.m. withdrawn from the HHS National
organizational entity or professional Agenda: To review and evaluate grant Laboratory Certification Program (NLCP)
applications.
affiliation. Place: National Institutes of Health Room
during the past month, it will be listed
Collection of this information is 3C100, 5601 Fishers Lane, Rockville, MD at the end and will be omitted from the
authorized under 42 U.S.C. 203, 24 1, 20892 (Telephone Conference Call). monthly listing thereafter.
2891–1 and 44 U.S.C. 310 I and Section Contact Person: Louis A. Rosenthal, Ph.D., This notice is also available on the
30 l and 493 of the Public Health Scientific Review Officer, Scientific Review Internet at http://www.samhsa.gov/
Service Act regarding the establishment Program, Division of Extramural Activities, workplace.
of the National Institutes of Health, its Rm 3G42B, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC–79823, FOR FURTHER INFORMATION CONTACT:
general authority to conduct and fund Giselle Hersh, Division of Workplace
research and to provide training Bethesda, MD 20892–9823, (240) 669–5070,
rosenthalla@niaid.nih.gov. Programs, SAMHSA/CSAP, Room 7–
assistance, and its general authority to 1051, One Choke Cherry Road,
maintain records in connection with (Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology, Rockville, Maryland 20857; 240–276–
these and its other functions. and Transplantation Research; 93.856, 2600 (voice), 240–276–2610 (fax).
Dated: September 24, 2015. Microbiology and Infectious Diseases SUPPLEMENTARY INFORMATION: The
Lawrence A. Tabak, Research, National Institutes of Health, HHS) Mandatory Guidelines were initially
Deputy Director, National Institutes of Health. Dated: September 24, 2015. developed in accordance with Executive
[FR Doc. 2015–25026 Filed 9–30–15; 8:45 am] David Clary, Order 12564 and section 503 of Pub. L.
BILLING CODE 4140–01–P Program Analyst, Office of Federal Advisory 100–71. The ‘‘Mandatory Guidelines for
Committee Policy. Federal Workplace Drug Testing
[FR Doc. 2015–24824 Filed 9–30–15; 8:45 am] Programs,’’ as amended in the revisions
DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P listed above, requires strict standards
HUMAN SERVICES that laboratories and IITFs must meet in
order to conduct drug and specimen
National Institutes of Health DEPARTMENT OF HEALTH AND validity tests on urine specimens for
HUMAN SERVICES federal agencies.
National Institute of Allergy and
To become certified, an applicant
Infectious Diseases; Notice of Closed Substance Abuse and Mental Health laboratory or IITF must undergo three
Meetings Services Administration rounds of performance testing plus an
Pursuant to section 10(d) of the on-site inspection. To maintain that
Federal Advisory Committee Act, as Current List of HHS-Certified certification, a laboratory or IITF must
amended (5 U.S.C. App.), notice is Laboratories and Instrumented Initial participate in a quarterly performance
hereby given of the following meetings. Testing Facilities Which Meet Minimum testing program plus undergo periodic,
The meetings will be closed to the Standards To Engage in Urine Drug on-site inspections.
public in accordance with the Testing for Federal Agencies Laboratories and IITFs in the
mstockstill on DSK4VPTVN1PROD with NOTICES6

provisions set forth in sections AGENCY: Substance Abuse and Mental applicant stage of certification are not to
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Health Services Administration, HHS. be considered as meeting the minimum
as amended. The grant applications and ACTION: Notice. requirements described in the HHS
the discussions could disclose Mandatory Guidelines. A HHS-certified
confidential trade secrets or commercial SUMMARY: The Department of Health and laboratory or IITF must have its letter of
property such as patentable material, Human Services (HHS) notifies federal certification from HHS/SAMHSA
and personal information concerning agencies of the laboratories and (formerly: HHS/NIDA), which attests
individuals associated with the grant Instrumented Initial Testing Facilities that it has met minimum standards.

VerDate Sep<11>2014 21:04 Sep 30, 2015 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\01OCN1.SGM 01OCN1

Document Created: 2015-12-15 08:40:21
Document Modified: 2015-12-15 08:40:21

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		To ensure consideration of your comments, responses must be received by November 2, 2015.
Contact		Dr. Karen Parker, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, Building 1, Room 257, 1 Center Drive, Bethesda, MD 20892, Telephone: 301-451-2055, Email: [email protected]
FR Citation		80 FR 59169

80 FR 59169 - The National Institutes of Health FY 2016-2020 Strategic Plan To Advance Research on the Health and Well-Being of Sexual and Gender Minorities (SGM) Request for Comments

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 190 (October 1, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health